CVR 45364577Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)København NFounded 29 Jan 2025
Employees
4
CVR registry, Aug 2026
+1 (+33.3%) over 12 months
Revenue
1M
DKK, annual report 2025
Result
-1.6M
DKK, annual report 2025
Equity
-1.6M
DKK, annual report 2025
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Akasi Pharma ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexWalden Holding ApSCVR 45348326, 50% to under 66.7% of capital and votes, since 29 Jan 2025
Venimic LLC25% to under 33.3% of capital and votes, since 29 Jan 2025
and 1 moreWalden Emil Bjørn-Yoshimotosince 29 Jan 2025
Helena Safavi-Hemamisince 29 Jan 2025
Equity was negative at 31 Dec 2025: -1.6M DKK. Dandex estimate, computed 31 Oct 2026.
CVR 4534832650% to under 66.7% of capital and votessince 29 Jan 2025
CVR 4595754310% to under 15% of capital and votessince 17 Oct 2025
25% to under 33.3% of capital and votessince 29 Jan 2025
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Ultimate controller
Holds 100% of capital and votes in Walden Holding ApS, since 22 Jan 2025
Holding company
CVR 45348326Private limited company (ApS)
Holds 50% to under 66.7% of capital and votes in Akasi Pharma ApS, since 29 Jan 2025
This company
Akasi Pharma ApS
CVR 45364577
CVR records founders at incorporation. It does not record whether they are alive or still involved.
29 Jan 2025 to 31 Oct 2026.
| Metric | 2025 |
|---|---|
| Revenue | 1,027 |
| Operating profit | -1,623 |
| Result for the year | -1,627 |
| Equity | -1,571 |
| Total assets | 2,486 |
| Credit metrics (Dandex calculations) | |
| EBIT margin (overskudsgrad) | -158.1% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | 1,566 |
DKK thousands. Annual reports via XBRL. 2025 covers 11 months (29 Jan to 31 Dec 2025).
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2025
29 Jan 2025 to 31 Dec 2025, published 12 Mar 2026
1 registered in CVR.
P-number 1031031903Ole Maaløes Vej 3, 2200 København N
No other current company drawn.
